Glycocalyx Biomarkers as Early Predictors of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Patients - Quiz - MDSpire

Glycocalyx Biomarkers as Early Predictors of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Patients

  • By

  • Uchida, Kimberly

  • Mahadeo, Kris Michael

  • McArthur, Jennifer Ann

  • Avent, Yvonne

  • Hsu, Chia-Wei

  • Pan, Haitao

  • Elbahlawan, Lama

  • Hines, Melissa R

  • Sharma, Akshay

  • Tatevossian, Ruth G

  • Mahapatra, Sebabrata

  • Kumbaji, Meenasri

  • Sheikh, Irtiza

  • Li, Ying

  • Schadler, Keri

  • Ghafoor, Saad

  • April 13, 2026

  • 0 min

Share

Original Source(s)

Glycocalyx Biomarkers as Early Predictors of Endotheliopathy in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Patients

  • by Uchida, Kimberly , Mahadeo, Kris Michael, McArthur, Jennifer Ann, Avent, Yvonne , Hsu, Chia-Wei , Pan, Haitao , Elbahlawan, Lama , Hines, Melissa R, Sharma, Akshay , Tatevossian, Ruth G, Mahapatra, Sebabrata , Kumbaji, Meenasri , Sheikh, Irtiza , Li, Ying , Schadler, Keri , Ghafoor, Saad

  • April 13, 2026

Related Content

This Week’s CGT News: Novo’s Parkinson’s Pivot

Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward

  • May 18, 2026

  • 7 min
Ruxolitinib for Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome: Two Pediatric Cases and Literature Review

Neurological manifestations in Wiskott–Aldrich syndrome: a systematic review